diflunisal has been researched along with Acute Myelogenous Leukemia in 1 studies
Diflunisal: A salicylate derivative and anti-inflammatory analgesic with actions and side effects similar to those of ASPIRIN.
diflunisal : An organofluorine compound comprising salicylic acid having a 2,4-difluorophenyl group at the 5-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shirakawa, K | 1 |
| Wang, L | 1 |
| Man, N | 1 |
| Maksimoska, J | 1 |
| Sorum, AW | 1 |
| Lim, HW | 1 |
| Lee, IS | 1 |
| Shimazu, T | 1 |
| Newman, JC | 1 |
| Schröder, S | 1 |
| Ott, M | 1 |
| Marmorstein, R | 1 |
| Meier, J | 1 |
| Nimer, S | 1 |
| Verdin, E | 1 |
1 other study available for diflunisal and Acute Myelogenous Leukemia
| Article | Year |
|---|---|
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Topics: Acetyl Coenzyme A; Acetylation; Animals; Antineoplastic Agents; Binding, Competitive; Catalytic Doma | 2016 |